Smart Pills Patient Monitoring Market Share

  • Report ID: 3864
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Smart Pills Patient Monitoring Market Share

North American Market Forecast   

The North American smart pills patient monitoring market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. The growth of the market can be attributed majorly to the higher frequency of colorectal cancer amongst people, backed by the rise in sedentary lifestyles, and the rapidly surging ratio of geriatric populace in the region. For instance, in the United States, there were reportedly more than 1 million people living with colorectal cancer in 2022. Whereas, more than 21 million individuals who were eligible for colorectal cancer screening had not received one. Moreover, growing healthcare expenditure and increasing investment in medical research activities are further anticipated to boost the regional market growth further during the forecast period.

APAC Market Statistics

The Asia Pacific smart pills patient monitoring market, amongst the market in all the other regions, is projected to grow with a notable CAGR during the forecast period. The growth of the market can be attributed majorly to the improving healthcare facilities, and economic development in countries, including, China, India, Japan, and others. In addition to this, the surging occurrence of several types of gastrointestinal disorders and stomach cancer is also projected to further boost the growth of the smart pills patient monitoring market in the region. For instance, gastric cancer is relatively frequent, particularly in Asian countries such as Japan, China, Mongolia, and the Republic of Korea. China accounts for around 44% of all stomach cancer cases worldwide, whereas it is the most common type of cancer among males in Japan. Further, the expanding governmental support to initiate awareness programs regarding the various types of cancer and their screening is also anticipated to boost the market growth during the forecast period in the APAC region.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3864
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of smart pills patient monitoring is evaluated at USD 6.63 Billion.

The smart pills patient monitoring market size was over USD 5.8 Billion in 2023 and is expected to exceed USD 39.46 Billion by the end of 2036, witnessing over 15.9% CAGR during the forecast period i.e., between 2024-2036. Increasing ratio of various types of chronic disorders, rising prevalence of gastrointestinal reflux disease (GERD), and worldwide increase in neurological disorders are the major factors driving the market growth.

North America is likely to dominate majority industry share by 2036, attributed to higher frequency of colorectal cancer amongst people, driven by rise in sedentary lifestyles, and rapidly surging ratio of geriatric populace in the region.

Medtronic plc, AbbVie Inc., Novartis AG, CapsoVision, Inc., Medimetrics, SA de CV, TauRx Pharmaceuticals Ltd, Otsuka Pharmaceutical Co. Ltd., FUJIFILM Holdings Corporation,
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample